万东医疗(600055) - 2025 Q3 - 季度财报
WDMWDM(SH:600055)2025-10-24 09:30

Financial Performance - The company's operating revenue for Q3 2025 was ¥345,179,582.58, a decrease of 12.17% compared to the same period last year[2] - The total profit for the period was -¥79,241,287.34, reflecting a significant decline of 315.69% year-over-year[2] - The net profit attributable to shareholders was -¥78,508,463.45, down 353.32% from the previous year[2] - Basic earnings per share for the period were -¥0.112, a decrease of 354.55% compared to the same period last year[2] - Net profit for the first three quarters of 2025 was a loss of CNY 27,546,471.83, compared to a profit of CNY 116,626,283.67 in the same period of 2024[19] - Earnings per share (EPS) for the first three quarters of 2025 was -CNY 0.039, down from CNY 0.165 in the same period of 2024[21] Cash Flow - The net cash flow from operating activities for the year-to-date was -¥403,852,005.54, a drastic decline of 1691.43%[2] - Cash flow from operating activities showed a net outflow of CNY 403,852,005.54, contrasting with a net inflow of CNY 25,376,678.78 in the previous year[24] - Net cash flow from investment activities was -329,288,779.09, an improvement from -466,001,126.70 in the previous period[25] - Total cash and cash equivalents at the end of the period decreased to 1,201,189,246.05 from 2,880,152,088.60[25] - Cash outflow from financing activities totaled 99,979,953.17, compared to 93,756,378.08 in the previous period[25] - Cash flow from financing activities resulted in a net outflow of -70,112,479.78, an improvement from -93,756,378.08[25] Assets and Liabilities - Total assets increased by 4.15% to ¥5,697,648,971.22 compared to the end of the previous year[3] - Total current assets as of September 30, 2025, amount to ¥4,645,884,057.69, an increase from ¥4,451,370,073.15 in the previous year[15] - Total liabilities as of September 30, 2025, are ¥904,542,516.14, compared to ¥592,503,982.96 in the previous year[16] - Total assets amount to ¥5,697,648,971.22, up from ¥5,470,493,043.29 year-over-year[15] - The company has no preferred shares or perpetual bonds listed in the non-current liabilities section[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 27,164[12] - The largest shareholder, Midea Group Co., Ltd., holds 319,579,981 shares, accounting for 45.46% of total shares[12] - The company has no significant changes in the top 10 shareholders or their shareholding status[13] Inventory and Receivables - Accounts receivable increased by 81.81%, attributed to changes in product sales structure and credit policy adjustments[9] - Inventory increased by 146.78%, mainly due to stockpiling for centralized procurement projects[10] - Accounts receivable increased to ¥693,079,736.66 from ¥381,205,179.51 year-over-year[15] - The company reported a significant increase in inventory, rising to ¥530,434,151.93 from ¥214,942,655.77[15] Operating Costs and Expenses - Total operating costs increased to CNY 1,236,567,549.40, up 27.1% from CNY 973,078,073.01 year-over-year[18] - The company reported a significant increase in sales expenses, which reached CNY 197,899,218.04, up 26.3% from CNY 156,722,078.95 year-over-year[18] - Research and development expenses rose to CNY 182,109,966.93, a significant increase of 57.5% from CNY 115,518,473.81 year-over-year[18] Investment Performance - Investment income for the first three quarters of 2025 was CNY 3,790,558.47, compared to CNY 2,917,381.98 in the same period of 2024, indicating improved performance in this area[19] - The company received CNY 762,000,000.00 from investment recoveries, an increase from CNY 583,590,000.00 in the previous year, highlighting effective investment management[24] - Cash inflow from investment activities was 765,752,612.22, up from 589,096,890.44[25] - Cash paid for investment activities was 1,042,000,000.00, slightly higher than 1,015,000,000.00 in the previous period[25] Accounting and Reporting - The company will not apply new accounting standards starting from 2025[26] - The board of directors announced the financial results on October 25, 2025[27]

WDM-万东医疗(600055) - 2025 Q3 - 季度财报 - Reportify